OBS! Ansökningsperioden för denna annonsen har
passerat.
Arbetsbeskrivning
We have exciting opportunities for curious, quantitatively-minded scientists as part of our capability build in Mölndal / Gothenburg Area, Sweden.
Do you want to push the boundary of science in order to deliver life-changing medicines?
Are you skilled in the quantitative disciplines and have experience in image analysis and machine learning?
Then joining Computational Biology may be the challenge you have been waiting for.
AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of prescription medicines for some of the world's most serious diseases. But we're more than one of the world's leading pharmaceutical companies. At AstraZeneca, we're proud to have a unique workplace culture that inspires innovation and collaboration. Here, employees are empowered to express diverse perspectives - and are made to feel valued, energized and rewarded for their ideas and creativity.
The Arena
You will be part of a dynamic team supporting AstraZeneca early stages of drug development pipeline, giving you exciting opportunities to interact with biologists by providing quantitative biology insights to improve the drug discovery process.
Our core competencies within Computational Biology span image analytics, bioinformatics and systems pharmacology. We are improving the biological understanding of the target and its engagement, including supporting the identification of molecular mechanisms of action, by providing image and data analysis solutions to high content phenotypic screening, and by enhancing AstraZenecas ability to prioritize target selection and portfolio projects based on probability of technical success.
The Role
Successful candidates will.........For full job description and to apply, please visit our career site: www.astrazeneca.se/karriar
For more information about the position please contact: Thierry Dorval at +44 016 025 510 324.
Welcome with your application no later than August 16, 2015.